CXCR4 and prostate neoplasm: This suggests that in hormone-naïve patients with organ-confined prostate tumors with presumably normal circulating levels of androgens (e.g., ~10-34 nM testosterone) [31], expression of the CXCR4 mRNA becomes de-repressed.